Chronic Inflammatory Demyelinating Polyneuropathy in a 39-Year-Old Nigerian Lady and Challenges of Care in a Resource Constrained Environment
Article Sidebar
Main Article Content
Abstract
A 39-year-old lady presented with progressive limb weakness of twelve (12) months duration with associated tingling, shock-like burning sensations on both hands and feet. Her physical examination revealed flaccid quadriparesis with moderate bilateral hand muscle atrophy as well as impairment in light, crude touch, and joint position sense. Laboratory and electrodiagnostic work up strongly suggested acquired immune mediated peripheral neuropathy. She received intravenous immunoglobulin and muscle power gradually improved. Apart from the high cost of intravenous immunoglobulin, other challenges were encountered in the course of management of this patient. The aim of this case report is to highlight the challenges of care of this condition in a resource poor setting.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31 (1):5-20.
Dimachkie MM, Barohn RJ. Chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol. 2013; 15(3):350-66.
Kuwabara S, Misawa S. Chronic inflammatory demyelinating polyneuropathy. AdvExp Med Biol. 2019; 1190:333-43.
Chen Y, Tang X. Chronic inflammatory demyelinating polyradiculoneuropathy in association with concomitant diseases: Identification and management. Front. Immunol. 2022;13: 890142
Rajabally YA, Simpson BS, Beri S, Bankart J, Gosalakkal JA. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: a study of a UK population. Muscle nerve. 2009;39(4):432-8.
Lewis RA, Muley SA. Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features and diagnosis. Available at https://www.uptodate.com. Last assessed on November 12 2022
Abiodun MT, Okunola P, Ofovwe GE, Iguodala O. Chronic inflammatory demyelinating polyneuropathy: a case report and review of literature. Ann Biomed Sci. 2013; 12(1).
Iyagba AM, Emem-Chioma PC. Chronic inflammatory demyelinating polyneuropathy presenting with autonomic symptoms: a case report. Int J Adv Med 2017; 4:282-5
Van den Berg PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of joint task –second version. Journal of the Peripheral Nervous system: JPNS. 2021; 26 (3):242-68.
Fisse AL, Motte J, Gruter et al. Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy. Neurol. Res. Pract. 2020; 2:42.
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculopathy (PREDICT study): a double-blind, randomized, controlled trial. Lancet Neurol. 2010;9(3):245-53.
Peltier AC, Donofrio PD. Chronic inflammatory polyradiculopathy: from bench to bedside. Semin Neurol. 2012; 32(3):187 195.
Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. The Lancet Neurol. 2019;18(8): 784-94.
Donneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filisto M et al. Antecedent events, lifestyle and dietary data from the Italian CIDP database study group. Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP database. Journal of Neurology, Neurosurgery and psychiatry. 2019;90(2) 125 -32.
Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neuropathy. 2000; 54(3): 615-20.
Rajabally YA, Chavada G. Lewis-Sumner syndrome of pure upper limb onset: Diagnostic, prognostic and therapeutic features. Muscle and Nerve. 2009;39(2):206-20.
Dyck PJB, Tracy JA. History, diagnosis and management of chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc. 2018;93(6):777-93.
Pasangulapati SB, Murthy TV, Sivadasan A, et al. The prevalence and severity of autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy. Ann Indian Acad Neurol. 2017; 20(3):274-7.
Van den Bergh PY, Jacquerye P, Pieret F. Electrodiagnosis of demyelinating neuropathies. Acta Neurol Belg. 2000; 100(3):188-95.
Doneddu PE, Cocito D, Manganelli D, Fazio R, Briani C, Filosto M, et al. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyneuropathy and their impact on clinical presentation and response to therapy. J Neurol Neurosurg Psychiatry.2020;92(10):1092-9
Suk JI, Walker FO, Cartwright MS. Ultrasonography of peripheral nerves. Curr Neurol Neurosci Rep. 2013; 13(2):328.
Vallat JM, Tabaraud F, Magy L, Torny F, Bernet-Bernady P, Macian F, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of 8 cases. Muscle Nerve.2003; 27(4):478-85.